NovoFine® Plus

  • 32G needles are associated with less pain compared to thicker* needles1
  • 4 mm needles are associated with less risk of intramuscular injections compared to 6 mm needles
  • Designed with SuperFlowTM Technology which results in better flow compared to thin walled needles3
  • Compatible with most pen devices4
  • Unique needle design to reduce the risk of bending or breaking5
  • 4 mm length is suitable for subcutaneous delivery, regardless of BMI6

*thicker needles include 27G, 28G, 30G, #31G

1. Arendt-Nielsen L et al. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23(1-2):37–43.

2. Birkebaek NH et al. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care. 2008;31(9):e65.

3. NovoFine plus: DVT report.

4. NovoFine plus: DVT report.

5. NovoFine plus: DVT report.

6. Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New Insulin Delivery Recommendations. Mayo Clin Proc. 2016;91(9):1231-55. #Yamada, 1967-PO 66th Annual Meeting and Scientific Sessions of the American Diabetes Association, 2006.